Table 1.
Categories of cost | Explanation | Calculations included |
---|---|---|
Start-up costs | ||
Clinical study preparation by study team | Costs associated with study team (excluding the principal investigator) in preparing industry- sponsored trials, including study tools, pre-initiation, and initiation meetings |
|
Uncompensated industry clinical study start-up, budget, and institutional review board (IRB) preparation |
Costs not associated with Clinical Trials Office (CTO) support or other centralized unit |
|
Non-industry study IRB full-board review | IRB costs associated with IRB reviewer’s efforts to conduct an IRB review and costs to support the review of a study |
|
Confidential disclosure agreement (CDA) negotiation | Costs to conduct negotiations with the sponsor for industry-sponsored clinical studies |
|
Clinical trial agreement (CTA) negotiation | Costs to conduct negotiations with the sponsor for industry-sponsored clinical studies |
|
Award set-up | Costs require to set up study accounts |
|
Maintenance costs | ||
Continuing IRB reviews | Costs associated with preparation of continuing reviews mandated by regulations |
|
Study modifications | Costs associated with study staff submission of modifications to a study during the enrollment period |
|
CTA amendments negotiation | Number of amendments of existing agreements that are processed annually |
|
Close-out costs | ||
Award close-out | Costs required to close an account at the end of the study |
|